Epigenetic Therapy for Friedreich’s Ataxia: a Phase 1, First in Man, Ascending Dose Crossover Study to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of Rg2833 (a Histone Deacetylase Inhibitor) in Adults With Friedreich’s Ataxia
Type: dissertation
Author: DE MERCANTI, STEFANIA FEDERICA
Institution: University of Turin
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7217790463
